Vantage Specialty Chemicals acquires German surfactant maker

By Deanna Utroske

- Last updated on GMT

© Getty Images / (Martin Barraud)
© Getty Images / (Martin Barraud)
The personal care ingredient maker announced the deal late last week. By adding LEUNA-Tenside GmbH to the Vantage business, the company hopes to expand its specialty personal care offerings and grow its reach in Europe.

Chicago, Illinois – based Vantage Specialty Chemicals was incorporated in 2008 (but the core of the business has been operating as a subsidiary of various companies for much longer). Currently, the global private equity firm H.I.G. Capital owns Vantage.

Vantage has manufacturing facilities throughout the US and sales offices in Europe, Africa, China, and Latin America. And, now the company has a surfactant-manufacturing subsidiary in Leuna, Germany.

“The acquisition of LTG is a transformational deal for Vantage that provides us with a strategic manufacturing footprint in Europe,” ​says Tiffany Kyllmann, chief strategy officer of Vantage, in a media release announcing the deal.

She continues, explaining that, “LTG’s production facility is attractively located in Germany with products and chemistries that are similar to those of Vantage. The synergistic combination of LTG with Vantage will bring enhanced value for our customers through a broader technology portfolio with expanded global manufacturing capacity and customer service.”

Trends and legacies

Vantage hopes that LTG's capacity to make niche and small volume products will give Vantage an advantage with customers formulating sulfate-free and soap-free personal care products.

At present, “LTG’s product portfolio includes anionic surfactants, nonionic surfactants, and emulsifiers that are based on naturally derived ingredients and are used in a diversified range of end markets including personal care, soaps and detergents, industrial cleaning, lubricants, and paints and coatings,”​ explains the media release.

And the new business comes with its own legacy in Europe too. LTG got its start in 1931 when “Prof. Carl Bosch (1874–1940) and Prof. Friedrich Bergius receive the Nobel Prize in Chemistry for the technical realization of the catalytic synthesis of ammonia,” ​according to an historical outline on the company’s site. In 1940, production of surfactants actually began at LTG.

“We are very excited to add LTG to the Vantage platform​,” Keval Patel, managing director at H.I.G., tells the press.

“This transaction fits our core strategic plan of expanding our manufacturing footprint globally with a core focus on the specialty personal care and food ingredients markets. We are very excited to partner with the LTG team as we grow our European business,” ​he says.



Deanna Utroske, Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers